Table 3.
CFF (Hz) | KW3110 Group (n = 28) | Placebo Group (n = 31) | ||||
---|---|---|---|---|---|---|
Week 0 | Week 4 | Week 8 | Week 0 | Week 4 | Week 8 | |
Before VDT load | 39.13 ± 2.47 | 39.57 ± 2.95 | 39.98 ± 2.94 | 39.03 ± 2.62 | 39.45 ± 2.36 | 39.77 ± 2.83 |
After VDT load | 37.68 ± 2.40 | 39.87 ± 2.52 ** | 39.56 ± 2.92 ** | 38.10 ± 2.97 | 39.24 ± 2.15 * | 39.95 ± 2.13 * |
Variation a | −1.45 ± 2.38 | 0.30 ± 2.70 * | −0.42 ± 2.31 | −0.94 ± 2.04 | −0.22 ± 2.03 | 0.17 ± 2.97 |
Data are expressed as the mean ± SD. The within-group comparisons between week 0 and week 4 or week 8 were carried out using a paired Student’s t-test with a Holm correction for multiple comparisons (** p < 0.01, * p < 0.05). a Variation indicated the difference of the values before and after the VDT load at each point. CFF = critical flicker frequency. VDT = visual display terminal. KW3110 = L. paracasei KW3110-treated group, placebo = control group.